Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25237402 | 1.00 | CNR2 (0.82) | CNR2CNR1 | |
| SCHEMBL25286196 | 1.00 | CNR2 (0.82) | CNR2CNR1 | |
| SCHEMBL30949048 | 0.99 | CNR2 (0.82) | CNR2CNR1 | |
| SCHEMBL25240259 | 0.96 | CNR2 (0.82) | CNR2CNR1 | |
| SCHEMBL30949050 | 0.92 | CNR2 (0.81) | CNR2CNR1 | |
| SCHEMBL22244830 | 0.90 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL7134748 | 0.90 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL31729573 | 0.90 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL22244859 | 0.90 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL7131677 | 0.89 | CNR2 (1.00) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4652994-A1 | COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY SKIN DISEASES, CONTAINING 1H-PYRAZOLE-3-AMIDE COMPOUND DERIVATIVE | Ajou University Industry-Academic Cooperation Foundation (KR) | 2025-11-26 | — | — | EP | claimed |
| US-20240382455-A1 | COMPOSITION CONTAINING 1H-PYRAZOLE-3-AMIDE-BASED COMPOUND DERIVATIVE FOR PREVENTION OR TREATMENT OF FIBROSIS | TSD LIFE SCIENCES CO., LTD. (KR) | 2024-11-21 | — | — | US | claimed |
| WO-2024154884-A1 | COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY SKIN DISEASES, CONTAINING 1H-PYRAZOLE-3-AMIDE COMPOUND DERIVATIVE | 아주대학교산학협력단 | 2024-07-25 | — | — | WO | claimed |
| US-20230172908-A1 | COMPOSITION CONTAINING 1H-PYRAZOLE-3-AMIDE-BASED COMPOUND DERIVATIVE FOR PREVENTION OR TREATMENT OF FIBROSIS | TSD LIFE SCIENCES CO., LTD. (KR) | 2023-06-08 | — | — | US | claimed |
| EP-4652994-A1 | COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY SKIN DISEASES, CONTAINING 1H-PYRAZOLE-3-AMIDE COMPOUND DERIVATIVE | Ajou University Industry-Academic Cooperation Foundation (KR) | 2025-11-26 | — | — | EP | disclosed |
| US-20240382455-A1 | COMPOSITION CONTAINING 1H-PYRAZOLE-3-AMIDE-BASED COMPOUND DERIVATIVE FOR PREVENTION OR TREATMENT OF FIBROSIS | TSD LIFE SCIENCES CO., LTD. (KR) | 2024-11-21 | — | — | US | disclosed |
| WO-2024154884-A1 | COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY SKIN DISEASES, CONTAINING 1H-PYRAZOLE-3-AMIDE COMPOUND DERIVATIVE | 아주대학교산학협력단 | 2024-07-25 | — | — | WO | disclosed |
| US-20230172908-A1 | COMPOSITION CONTAINING 1H-PYRAZOLE-3-AMIDE-BASED COMPOUND DERIVATIVE FOR PREVENTION OR TREATMENT OF FIBROSIS | TSD LIFE SCIENCES CO., LTD. (KR) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240382455-A1 | COMPOSITION CONTAINING 1H-PYRAZOLE-3-AMIDE-BASED COMPOUND DERIVATIVE FOR PREVENTION OR TREATMENT OF FIBROSIS | HDAC3, IL33, HDAC1 | CNR2 2063/4885CNR1 1762/4885 |
| US-20230172908-A1 | COMPOSITION CONTAINING 1H-PYRAZOLE-3-AMIDE-BASED COMPOUND DERIVATIVE FOR PREVENTION OR TREATMENT OF FIBROSIS | HDAC3, IL33, HDAC1 | CNR2 2063/4885CNR1 1762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.